Unknown

Dataset Information

Widely available lysosome targeting agents should be considered as potential therapy for COVID-19.


ABSTRACT: While the coronavirus disease 2019 (COVID-19) pandemic advances, the scientific community continues to struggle in the search for treatments. Several improvements have been made, including discovery of the clinical efficacy of chloroquine (CQ) in patients with COVID-19, but effective treatment protocols remain elusive. In the search for novel treatment options, many scientists have used the in-silico approach to identify compounds that could interfere with the key molecules involved in entrance, replication or dissemination of severe acute respiratory syndrome coronavirus-2. However, most of the identified molecules are not available as pharmacological agents at present, and assessment of their safety and efficacy could take many months. This review took a different approach based on the p

SUBMITTER: Homolak J 

PROVIDER: S-EPMC7275137 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature